
CEMI
Healthcare · Diagnostics & Research · $16.7M market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Jun 30, 2022
EPS trend, 90 days to now · +100.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Mar 29, 2023 | After the close | -0.22 | -0.02 | +90.9% |
| Nov 3, 2022 | After the close | -0.19 | -0.21 | -10.5% |
| Aug 4, 2022 | After the close | -0.19 | -0.23 | -21.1% |
| May 5, 2022 | After the close | -0.21 | -0.29 | -38.1% |
| Mar 3, 2022 | After the close | -0.20 | -0.47 | -135.0% |
| Nov 4, 2021 | After the close | -0.19 | -0.24 | -26.3% |
| Aug 5, 2021 | After the close | -0.37 | -0.45 | -21.6% |
| May 6, 2021 | After the close | -0.32 | -0.22 | +31.3% |
| Mar 11, 2021 | After the close | -0.28 | -0.35 | -25.0% |
| Nov 5, 2020 | After the close | -0.26 | -0.28 | -7.7% |
| Aug 6, 2020 | After the close | -0.39 | -0.40 | -2.6% |
| May 4, 2020 | After the close | -0.23 | -0.25 | -8.7% |
| Mar 12, 2020 | After the close | -0.24 |
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID 19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, rickettsia, and Burkholderia diseases. The…
| -0.24 |
| 0.0% |
| Nov 7, 2019 | After the close | -0.17 | -0.22 | -29.4% |
| Aug 6, 2019 | After the close | -0.15 | -0.19 | -26.7% |
| May 1, 2019 | After the close | -0.15 | -0.14 | +6.7% |
| Mar 7, 2019 | After the close | -0.17 | -0.21 | -23.5% |
| Nov 8, 2018 | After the close | -0.06 | -0.16 | -166.7% |
| Aug 8, 2018 | After the close | -0.07 | -0.12 | -71.4% |
| May 9, 2018 | After the close | -0.14 | -0.05 | +64.3% |
| Mar 8, 2018 | After the close | -0.10 | -0.16 | -60.0% |